Johnson & Johnson SC 13G and SC 13G/A reports

Location
One Johnson & Johnson Plz, New Brunswick, New Jersey
State of incorporation
New Jersey
Fiscal year end
December 29
Data updated at
8/10/2024, 01:30 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Jul 30, 2024
SC 13G/A Report SCHEDULE 13G/A May 20, 2024
SC 13G Report Apr 10, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 2, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 2, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 2, 2024
SC 13G/A Report Jan 30, 2024
SC 13G/A Report Jan 26, 2024
SC 13G Report SCHWEDULE 13G Jan 24, 2024
SC 13G/A Report Feb 10, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G/A Report Jan 31, 2023
SC 13G/A Report SCHEDULE 13G/A Jan 27, 2023
SC 13G/A Report SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON Jan 11, 2023
SC 13G/A Report SC 13G/A Nov 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2022
SC 13G Report SCHEDULE 13G FOR CVRX, INC. Feb 7, 2022
SC 13G/A Report SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC. Feb 1, 2022
SC 13G/A Report Feb 1, 2022
SC 13G Report Feb 12, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 2, 2021
SC 13G/A Report Jan 29, 2021
SC 13G Report SCHEDULE 13G FOR FUSION PHARMACEUTICALS INC. BY JOHNSON & JOHNSON Jul 6, 2020
SC 13G Report Feb 13, 2020
SC 13G/A Report SCHEDULE 13G/A Feb 12, 2020
SC 13G/A Report Feb 10, 2020
SC 13G/A Report SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON, DATED 12.3 Jan 17, 2020
SC 13G/A Report SCH 13GA - FILER JOHNSON & JOHNSON, SUBJECT - PROVENTION BIO, DTD 12/31/19 Jan 17, 2020
SC 13G Report SC 13G Nov 26, 2019
SC 13G Report SCHEDULE 13G FOR MEIRAGTX HOLDINGS PLC BY JOHNSON & JOHNSON. Mar 4, 2019
SC 13G Report JOHNSON & JOHNSON Feb 13, 2019
SC 13G/A Report Feb 11, 2019
SC 13G/A Report Feb 11, 2019
SC 13G/A Report SCHEDULE 13G-A FOR GI DYNAMICS, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G Report SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G Report SCHEDULE 13G FOR PROVENTION BIO, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G/A Report SCHEDULE 13G-A FOR MERUS N.V. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G/A Report SCHEDULE 13G-A FOR MACROGENICS, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G/A Report SCHEDULE 13G-A FOR ADURO BIOTECH, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G/A Report SCHEDULE 13G-A FOR ALDEYRA THERAPEUTICS, INC. BY JOHNSON & JOHNSON Jan 22, 2019
SC 13G Report JOHNSON & JOHNSON Feb 14, 2018
SC 13G/A Report Feb 9, 2018
SC 13G/A Report Feb 8, 2018
SC 13G/A Report SCHED13G/A SUBMITTED ON 1-16-18 FOR JOHNSON & JOHNSON AND TRACON PHARMACEUTICALS Jan 22, 2018
SC 13G/A Report SCH13G/A RECEIVED IN DP ON 1-16-18 FOR JOHNSON & JOHNSON AND CATALYST BIOSCIENCE Jan 22, 2018
SC 13G/A Report SC 13G/A FOR ACHILLION PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON Nov 22, 2017
SC 13G/A Report FORM SC 13G/A FOR MINERVA NEUROSCIENCES, INC. BY JOHNSON & JOHNSON Sep 14, 2017
SC 13G/A Report Feb 10, 2017
SC 13G Report JOHNSON & JOHNSON Feb 7, 2017
SC 13G/A Report Jan 25, 2017
SC 13G Report Jan 18, 2017
SC 13G/A Report Jan 18, 2017
SC 13G Report SCHEDULE 13G FOR TRACON PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON Oct 31, 2016
SC 13G Report Aug 19, 2016
SC 13G Report JOHNSON & JOHNSON Feb 16, 2016
SC 13G/A Report SC 13G/A FOR MINERVA NEUROSCIENCES, INC. BY JOHNSON & JOHNSON Feb 12, 2016
SC 13G/A Report SCHEDULE 13G/A FOR AQUINOX PHARMACEUTICALS Feb 12, 2016
SC 13G/A Report SCHEDULE 13G/A FOR NEVRO CORP. Feb 12, 2016
SC 13G Report SCHEDULE 13G Feb 12, 2016
SC 13G/A Report SCHEDULE 13G/A FOR GENOCEA BIOSCIENCES Feb 12, 2016
SC 13G/A Report Feb 10, 2016
SC 13G/A Report Feb 10, 2016
SC 13G Report SCHEDULE 13G Aug 28, 2015
SC 13G Report SCHEDULE 13G Jul 7, 2015
SC 13G Report JNJ Feb 12, 2015
SC 13G Report Feb 10, 2015
SC 13G/A Report Feb 9, 2015
SC 13G Report SCHEDULE 13G FOR GI DYNAMICS BY JOHNSON & JOHNSON Feb 6, 2015
SC 13G Report SCHEDULE 13G FOR AQUINOX PHARMACEUTICALS FOR JOHNSON & JOHNSON Feb 6, 2015
SC 13G Report SCHEDULE 13G FOR MACROGENICS, INC. BY JOHNSON & JOHNSON Feb 5, 2015
SC 13G Report SCHEDULE 13G FOR ALDEYRA THERAPEUTICS BY JOHNSON & JOHNSON Feb 5, 2015
SC 13G Report SCHEDULE 13G FOR NEVRO CORP. BY JOHNSON & JOHNSON Feb 5, 2015
SC 13G Report SCHEDULE 13G FOR GENOCEA BIOSCIENCES BY JOHNSON & JOHNSON Feb 5, 2015
SC 13G Report S13G FOR MINERVA NEUROSCIENCES, INC. BY JOHNSON & JOHNSON Jul 17, 2014
SC 13G Report JNJ Feb 3, 2014
SC 13G/A Report Jan 29, 2014
SC 13G/A Report AMENDMENT NO. 1 Oct 10, 2013
SC 13G/A Report AMENDMENT NO. 1 Apr 19, 2013
SC 13G Report SCHEDULE 13G Feb 13, 2013
SC 13G/A Report S 13 G/A AMENDMENT NO. 3 - FOR JOHNSON & JOHNSON - UNIVERSAL BIOSENSORS INC. Feb 12, 2013
SC 13G Report Feb 11, 2013
SC 13G/A Report Feb 11, 2013
SC 13G/A Report Feb 13, 2012
SC 13G Report JOHNSON & JOHNSON ANNUAL Feb 9, 2012
SC 13G/A Report S 13 G/A AMENDMENT NO. 2 - FOR JOHNSON & JOHNSON - UNIVERSAL BIOSENSORS INC. Jan 25, 2012
SC 13G/A Report SCHEDULE 13 G/A - 1-19-12 FOR JOHNSON & JOHNSON - TENGION, INC. Jan 25, 2012
SC 13G/A Report FORM S 13 G/A - 1-19-12 FOR JOHNSON & JOHNSON - LPATH, INC. Jan 24, 2012
SC 13G Report Feb 11, 2011
SC 13G Report 13G FOR TENGION INC. BY JOHNSON & JOHNSON Feb 10, 2011
SC 13G/A Report AMENDMENT TO 13G FOR UNIVERSAL BIOSENSORS BY JOHNSON & JOHNSON Feb 10, 2011
SC 13G/A Report Feb 4, 2011
SC 13G/A Report Feb 9, 2010
SC 13G/A Report AMD TO SCHED 13G FOR OPKO HEALTH BY JOHNSON & JOHNSON Feb 3, 2010
SC 13G Report Jan 29, 2010